Back
Compare AU
Compare MVE vs. HLTH
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the VanEck S&P/ASX Midcap ETF (MVE) and the VanEck Global Healthcare Leaders ETF (HLTH). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
MVE | HLTH | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 47 | 57 |
Median incremental investment | $930.00 | $550.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $3,649.65 | $1,367.72 |
Average age group | > 35 | > 35 |
Key Summary
MVE | HLTH | |
|---|---|---|
Strategy | MVE.AX was created on 2013-10-14 by VanEck. The fund's investment portfolio concentrates primarily on mid cap equity. The Fund is designed to capture the performance of the 50 midcap companies listed on ASX having Market Capitalisation ranking from 51 to 100. | HLTH.AX was created on 2020-09-08 by VanEck. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investment returns before fees and other costs which track the performance of the Reference Index in Australian dollars. |
Top 3 holdings | Nextdc Ltd (3.73 %) ALS Ltd (3.72 %) Mineral Resources Ltd (3.68 %) | Illumina Inc (2.79 %) Arrowhead Pharmaceuticals Inc (2.76 %) West Pharmaceutical Services Inc (2.71 %) |
Top 3 industries | Materials (20.27 %) Consumer Discretionary (20.22 %) Real Estate (18.54 %) | Health Care (100.00 %) Other (9.10 %) |
Top 3 countries | Australia (87.98 %) United States (6.16 %) United Kingdom of Great Britain and Northern Ireland (2.27 %) | United States (65.74 %) Japan (10.95 %) Denmark (8.04 %) |
Management fee | 0.45 % | 0.45 % |
Key Summary
MVE | HLTH | |
|---|---|---|
Issuer | VanEck | VanEck |
Tracking index | S&P/ASX Midcap 50 Index - AUD | MarketGrader Developed Markets ex-Australia Health Care Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.45 % | 0.45 % |
Price | $41.84 | $11.17 |
Size | $484.506 million | $48.681 million |
10Y return | 101.25 % | N/A |
Annual distribution yield (5Y) | 2.80 % | 0.61 % |
Market | ASX | ASX |
First listed date | 16/10/2013 | 09/09/2020 |
Purchase fee | $6.50 | $6.50 |
Community Stats
MVE | HLTH | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 47 | 57 |
Median incremental investment | $930.00 | $550.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $3,649.65 | $1,367.72 |
Average age group | > 35 | > 35 |
Pros and Cons
MVE | HLTH | |
|---|---|---|
Pros |
|
|
Cons |
|
|
MVE | HLTH |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Lower exposure to US market | Higher exposure to US market |
Higher price growth | Lower price growth |
Higher distribution yield | Lower distribution yield |